Reduced risk of secondary leukemia with fewer cycles of dose-intensive induction chemotherapy in patients with neuroblastoma.

Pediatric Blood & Cancer
Brian H KushnerNai-Kong V Cheung

Abstract

We report a prospective study of secondary leukemia (SL)/myelodysplastic syndrome (MDS) in neuroblastoma (NB) patients treated with > or =5 cycles of dose-intensive chemotherapy. NB patients received induction with high-dose cyclophosphamide (4,200 mg/m(2))-doxorubicin (75 mg/m(2))-vincristine (cycles 1, 2, 4, 6, 8), and high-dose cisplatin (200 mg/m(2))-etoposide (600 mg/m(2)) (cycles 3, 5, 7). Bone marrow was examined every 1-3 months for > or =36 months, with inclusion of extensive chromosomal studies 1-3 months post-induction and 1-2x/year thereafter. One hundred eight four patients received 5 (n = 76), 6 (n = 45), 7 (n = 59), or 8 (n = 4) cycles. Eight patients developed SL/MDS (only one each in the 5- and 6-cycle groups), at 12-50 months, including two cases detected in surveillance studies. Among 108 patients who received > or =6 cycles, the 5-year cumulative incidence was 7.1% (95% CI: 2%, 12.2%), versus 0% among 54 patients who received 5 cycles without maintenance oral etoposide. Five-year cumulative incidences were 1.46%, 2.28%, and 8.47% among patients in the 5-, 6-, and 7-cycle groups, with fewer cycles having a significantly lower risk (P = 0.048). There was no significant association of risk with potentially leuk...Continue Reading

References

Apr 1, 1980·The Journal of Allergy and Clinical Immunology·S R Hirsch, J H Kalbfleisch
Jun 1, 1993·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·C SandovalD R Head
Feb 1, 1996·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·L B TravisJ D Boice
Sep 17, 1998·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·B H KushnerP A Meyers
Dec 16, 1998·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·B H KushnerS C Jhanwar
Mar 18, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M A SmithD Vena
Oct 3, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·B H KushnerN K Cheung
Dec 22, 1999·International Journal of Cancer. Journal International Du Cancer·C KollmannsbergerC Bokemeyer
Mar 8, 2000·Proceedings of the National Academy of Sciences of the United States of America·M D MegonigalC A Felix
Jun 10, 2000·British Journal of Haematology·C H Pui, M V Relling
May 8, 2001·Medical and Pediatric Oncology·C A Felix
May 8, 2001·Medical and Pediatric Oncology·S M Davies
Jun 2, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·B H KushnerN K Cheung
Feb 2, 2002·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M PaulussenH Jürgens
Apr 4, 2002·Proceedings of the National Academy of Sciences of the United States of America·Leslie J RaffiniCarolyn A Felix
Mar 15, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Marie-Cécile Le DeleyUNKNOWN Société Française d'Oncologie Pédiatrique
Mar 29, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Roy E SmithUNKNOWN National Surgical Adjuvant Breast and Bowel Project Experience
Mar 29, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·K Scott BakerLeslie L Robison
Apr 16, 2003·International Journal of Radiation Oncology, Biology, Physics·Daphne A Haas-KoganKatherine K Matthay
Dec 22, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Brian H KushnerNai-Kong V Cheung
Jan 22, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Dominique Valteau-CouanetOlivier Hartmann
May 4, 2005·Blood·Oliver TeuffelBeat W Schäfer
Dec 13, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Marie-Cécile Le DeleyCatherine Hill
Jan 26, 2007·Pediatric Blood & Cancer·J A KohlerUNKNOWN Neuroblastoma Working Group of the Children's Cancer and Leukaemia Group
Feb 10, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Cameron K TebbiCindy L Schwartz

❮ Previous
Next ❯

Citations

May 15, 2013·Bone Marrow Transplantation·T SchechterP C Nathan
Oct 20, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Julie R ParkKatherine K Matthay
Dec 2, 2014·Pediatric Clinics of North America·Meredith S Irwin, Julie R Park
Nov 12, 2013·British Medical Bulletin·Lucas MorenoAndrew D J Pearson
Jan 19, 2016·Current Opinion in Hematology·Virginia M Klimek, Nancy J Tray
Oct 12, 2010·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Brian H KushnerNai-Kong V Cheung
May 12, 2009·Pediatric Blood & Cancer·Carolyn A Felix
Jan 3, 2013·Pediatric Blood & Cancer·Lucas MorenoUNKNOWN Children's Cancer and Leukaemia Group (CCLG) (formerly UKCCSG)
Feb 19, 2014·Pediatric Blood & Cancer·Alberto Garaventa
Nov 15, 2011·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Rachel KobosFarid Boulad
Jun 16, 2016·Pediatric Blood & Cancer·Cormac OwensMeredith S Irwin
Aug 8, 2018·Children·Danielle Novetsky Friedman, Tara O Henderson
Nov 7, 2012·Annals of Pediatric Cardiology·Saleem AkhtarMehnaz Atiq Ahmed
May 12, 2020·Experimental Biology and Medicine·K KoślaA K Bednarek

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

The Lancet Oncology
Andrew D J PearsonChildren's Cancer and Leukaemia Group (CCLG formerly United Kingdom Children's Cancer Study Group)
European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)
Fariba NavidCarlos Rodriguez-Galindo
© 2021 Meta ULC. All rights reserved